Showing results (221-230 of 230) with videos related to
Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
Leukemia|August 23, 2018
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.Leukemia|July 16, 2020
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.Cancer Discovery|November 13, 2021
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified NeuroblastomaAdam D Durbin, Tingjian Wang, Virangika K Wimalasena, et al.Nature|May 23, 2007
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersRichard S Maser, Bhudipa Choudhury, Peter J Campbell, et al.Nature Cell Biology|October 27, 2014
Cyclin C is a haploinsufficient tumour suppressorNa Li, Anne Fassl, Joel Chick, et al.Nature Chemical Biology|April 7, 2020
Discovery of a selective inhibitor of doublecortin like kinase 1Fleur M Ferguson, Behnam Nabet, Srivatsan Raghavan, et al.The Journal of Clinical Investigation|April 15, 2024
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemiaTobias Suske, Helena Sorger, Gabriele Manhart, et al.Nature Communications|September 23, 2021
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphomaHuan-Chang Liang, Mariantonia Costanza, Nicole Prutsch, et al.Nature Chemical Biology|May 11, 2021
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivoChristian Dubiella, Benika J Pinch, Kazuhiro Koikawa, et al.Cancer Cell|April 13, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.Pageof 23